ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk

May 2, 2003

Roswell Park Researchers Win $1.6M For Tobacco Studies.

June 20, 2003

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

Toxicology Program Seeks Comment On Substances.

March 23, 2001

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

Senate Approves $1 Billion For NCI

July 27, 1979